1. Bioavailability of omega-3 essential fatty acids from perilla seed oil.
- Author
-
Kurowska EM, Dresser GK, Deutsch L, Vachon D, and Khalil W
- Subjects
- Adolescent, Adult, Biological Availability, Cross-Over Studies, Docosahexaenoic Acids administration & dosage, Docosahexaenoic Acids pharmacokinetics, Eicosapentaenoic Acid, Fatty Acids, Essential administration & dosage, Fatty Acids, Omega-3 administration & dosage, Fatty Acids, Unsaturated administration & dosage, Fatty Acids, Unsaturated pharmacokinetics, Female, Humans, Male, Middle Aged, Perilla, Plant Oils administration & dosage, Plant Oils chemistry, Tablets, Enteric-Coated, alpha-Linolenic Acid administration & dosage, alpha-Linolenic Acid chemistry, Fatty Acids, Essential pharmacokinetics, Fatty Acids, Omega-3 pharmacokinetics, Plant Oils pharmacokinetics, alpha-Linolenic Acid pharmacokinetics
- Abstract
Increased dietary intake of fish oil omega-3 fatty acids, eicosapentanoic acid and docosohexanoic acid, and their precursor, alpha-linolenic acid (ALA), is associated with various health benefits. Enteric-coating (Entrox), which improves stability of omega-3 capsules, has been shown to facilitate fish oil absorption after chronic treatment. To assess the effect of Entrox coating on the short-term bioavailability of ALA administered in the form of ALA-rich Perilla seed oil, 12 healthy subjects (6 males and 6 females) received in a random order Entrox-coated and non-coated ALA formulations, each as a single 6g dose separated by a 3-week washout period. Measurements of plasma ALA concentrations from 0 to 24h showed no difference in ALA pharmacokinetics between the two formulations. However, significantly greater increases in plasma ALA levels from baseline to 24h were observed after ingestion of Entrox vs. non-coated product, suggesting a possible benefit of Entrox with long-term treatment.
- Published
- 2003
- Full Text
- View/download PDF